Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer.

Cancer treatment and research

Volumn 81, Issue , 1996, Pages 169-176

  Fujimoto, S ^a   Takahashi, M ^a   Mutou, T ^a   Kobayashi, K ^a   Toyosawa, T ^a   Kondoh, K ^a   Ohkubo, H ^a  

^a Social Ins Funabashi Ctrl Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN; PROTEIN;

ADULT; AGED; ARTICLE; DUODENOSTOMY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; REGIONAL PERFUSION; STOMACH TUMOR; SURVIVAL RATE;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DUODENOSTOMY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; PROTEINS; STOMACH NEOPLASMS; SURVIVAL RATE;

MLCS; MLOWN;

EID: 0029681998     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4613-1245-1_14     Document Type: Article

References (0)